Literature DB >> 9113500

Mitochondrial tRNA(Gln) and tRNA(Thr) gene variants in Parkinson's disease.

U Mayr-Wohlfart1, G Rödel, A Henneberg.   

Abstract

A number of neurodegenerative diseases including Parkinson's disease (PD) have been shown to be associated with polymorphic variants of mitochondrial DNA. The A4336G mutation in the tRNA(Gln) gene was reported to occur at a higher frequency in individuals with Parkinson's disease and Alzheimer's disease (AD) than in age-matched controls. Similarly, we recently noted an elevated frequency of alterations at positions 15927 and 15928 in the tRNA(Thr) gene, resulting in the loss of a HpaII site, in patients suffering from multiple sclerosis (MS) with severe optic involvement. Here we report on the result of screening 100 PD patients and 100 age- and sex-matched controls for the presence of the A4336G mutation and the loss of the HpaII site in the tRNA(Thr) gene. Our result shows that loss of the HpaII site is significantly more frequent in patients than in controls. In contrast, we were not able to detect a difference in the frequency of the A4336G mutation in the tRNA(Gln) gene between patients and controls.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9113500

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  13 in total

1.  Mitochondrial genetic background plays a role in increasing risk to asthma.

Authors:  Emily Zifa; Zoe Daniil; Eleutheria Skoumi; Maria Stavrou; Kostantinos Papadimitriou; Marini Terzenidou; Konstantinos Kostikas; Vasileios Bagiatis; Konstantinos I Gourgoulianis; Zissis Mamuris
Journal:  Mol Biol Rep       Date:  2011-09-24       Impact factor: 2.316

2.  Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson's disease.

Authors:  Russell H Swerdlow; Bradley Weaver; Amy Grawey; Connie Wenger; Eric Freed; Bradford B Worrall
Journal:  J Neurol Sci       Date:  2006-06-19       Impact factor: 3.181

Review 3.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

4.  Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia.

Authors:  Pinar E Coskun; Joanne Wyrembak; Olga Derbereva; Goar Melkonian; Eric Doran; Ira T Lott; Elizabeth Head; Carl W Cotman; Douglas C Wallace
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Presence of mitochondrial tRNA(Leu(UUR)) A to G 3243 mutation in DNA extracted from serum and plasma of patients with type 2 diabetes mellitus.

Authors:  S Zhong; M C Ng; Y M Lo; J C Chan; P J Johnson
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

6.  Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons.

Authors:  J Zhang; G Perry; M A Smith; D Robertson; S J Olson; D G Graham; T J Montine
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

Review 7.  Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

Review 8.  Mitochondrial DNA, base excision repair and neurodegeneration.

Authors:  Nadja C de Souza-Pinto; David M Wilson; Tinna V Stevnsner; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2008-05-16

9.  Do somatic mitochondrial DNA mutations contribute to Parkinson's disease?

Authors:  Joanne Clark; Ying Dai; David K Simon
Journal:  Parkinsons Dis       Date:  2011-04-27

10.  Female genetic distribution bias in mitochondrial genome observed in Parkinson's Disease patients in northern China.

Authors:  Qiaohong Chu; Xiaoguang Luo; Xiaoni Zhan; Yan Ren; Hao Pang
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.